OCIAD1 Antibody [mFluor Violet 500 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97855MFV500
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
mFluor Violet 500 SE (Excitation = 410 nm, Emission = 501 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with E. coli-derived Human OCIAD1 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for OCIAD1 Antibody [mFluor Violet 500 SE]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OCIAD1
Alternate Names
Asrij, MGC111072, OCIA domain containing 1, OCIA domain-containing protein 1, OCIAFLJ20455, Ovarian carcinoma immunoreactive antigen, TPA018
Gene Symbol
OCIAD1
Additional OCIAD1 Products
Product Documents for OCIAD1 Antibody [mFluor Violet 500 SE]
Product Specific Notices for OCIAD1 Antibody [mFluor Violet 500 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...